VAXMIVA

Johnson & Johnson

Application Filed: 2019-07-23
Trademark Application Details
Trademark Logo VAXMIVA

Mark For: VAXMIVA™ trademark registration is intended to cover the categories of human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives. [all]

Status

2020-03-14 UTC
LIVE APPLICATION Published for Opposition
A pending trademark application has been examined by the Office and has been published in a way that provides an opportunity for the public to oppose its registration.


Research OneLook Acronym Finder
Serial Number88530304
Mark Literal ElementsVAXMIVA
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationINTENT TO USE SECTION 2020-01-14
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameCheryl L Foytlin
Attorney Docket NumberT40855US2
Law Office AssignedN40
Employee NameMOLINOFF, JEFFREY S.

Timeline

2019-07-23Application Filed
2019-10-15Location: PUBLICATION AND ISSUE SECTION
2019-11-19Published
2019-11-19Published for Opposition
2019-11-19Status: Live/Pending
2019-12-06Transaction Date
2020-01-14Location: INTENT TO USE SECTION
2020-01-14Status: Notice of Allowance (NOA) sent (issued) to the applicant. Applicant must file a Statement of Use or Extension Request within six

Trademark Parties (Applicants & Owners)

Party: Johnson & Johnson
AddressOne Johnson & Johnson Plaza New Brunswick, NEW JERSEY UNITED STATES 08933
Legal Entity TypeCorporation
Legal Entity StateNEW JERSEY
Party: Johnson & Johnson
AddressOne Johnson & Johnson Plaza New Brunswick NJ 08933
Legal Entity Type
Legal Entity StateNJ

*multiple parties listed, check assignment documents for ownership information

Documents

DrawingJPEG2019-07-23
TEAS RF New ApplicationMULTI2019-07-23
Notation to FileXML2019-10-11
XSearch Search SummaryXML2019-10-11
TRAM Snapshot of App at Pub for OppostnAPPLICATION/XML,IMAGE/JPEG2019-10-12
Notice of PublicationXML2019-10-30
Notification Of Notice of PublicationXML2019-10-30
OG Publication ConfirmationXML2019-11-19
Notice of AllowanceAPPLICATION/XML2020-01-14

Attorney of Record

CHERYL L FOYTLIN
JOHNSON & JOHNSON
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK, NJ 08933-7001

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

Trademark Filing History

DescriptionDateProceeding Number
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2020-01-14
PUBLISHED FOR OPPOSITION2019-11-19
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2019-11-19
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2019-10-30
ASSIGNED TO EXAMINER2019-10-1176427
APPROVED FOR PUB - PRINCIPAL REGISTER2019-10-11
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2019-07-31
NEW APPLICATION ENTERED IN TRAM2019-07-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed